Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889–916.

Article  CAS  PubMed  Google Scholar 

Young WF Jr. Diagnosis and treatment of primary aldosteronism: practical clinical perspectives. J Intern Med. 2019;285:126–48.

Article  PubMed  Google Scholar 

Huang KH, Yu CC, Hu YH, Chang CC, Chan CK, Liao SC, et al. TAIPAI, Taiwan Primary Aldosteronism Investigator. Targeted treatment of primary aldosteronism - The consensus of Taiwan Society of Aldosteronism. J Formos Med Assoc. 2019;118:72–82.

Article  PubMed  Google Scholar 

Rossi GP, Bisogni V, Bacca AV, Belfiore A, Cesari M, et al. The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism. Int J Cardiol Hypertens. 2020;5:100029.

Article  PubMed  PubMed Central  Google Scholar 

Mulatero P, Sechi LA, Williams TA, Lenders JWM, Reincke M, Satoh F, et al. Subtype diagnosis, treatment, complications and outcomes of primary aldosteronism and future direction of research: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J Hypertens. 2020;38:1929–36.

Article  CAS  PubMed  Google Scholar 

Naruse M, Katabami T, Shibata H, Sone M, Takahashi K, Tanabe A, et al. Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. Endocr J. 2022;69:327–59.

Article  PubMed  Google Scholar 

Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diab Endocrinol. 2018;6:51–9.

Article  Google Scholar 

Monticone S, D’Ascenzo F, Moretti C, Williams TA, Veglio F, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diab Endocrinol. 2018;6:41–50.

Article  CAS  Google Scholar 

Tezuka Y, Turcu AF. Real-world effectiveness of mineralocorticoid receptor antagonists in primary aldosteronism. Front Endocrinol. 2021;12:625457.

Article  Google Scholar 

Deinum J, Riksen NP, Lenders JW. Pharmacological treatment of aldosterone excess. Pharmacol Ther. 2015;154:120–33.

Article  CAS  PubMed  Google Scholar 

Stavropoulos K, Papadopoulos C, Koutsampasopoulos K, Lales G, Mitas C, Doumas M. Mineralocorticoid receptor antagonists in primary aldosteronism. Curr Pharm Des. 2018;24:5508–16.

Article  CAS  PubMed  Google Scholar 

Young WF. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol. 2007;66:607–18.

Article  CAS  Google Scholar 

Wang X, Luo Q, Wang M, Hu J, Zhang D, Zhang W, et al. Long-term impact of spironolactone compliance on microalbuminuria in patients with primary aldosteronism. Hypertens Res. 2021;44:426–34.

Article  CAS  PubMed  Google Scholar 

Araujo-Castro M, Paja Fano M, González Boillos M, Pla Peris B, Pascual-Corrales E, García Cano AM, et al. Evolution of the cardiometabolic profile of primary hyperaldosteronism patients treated with adrenalectomy and with mineralocorticoid receptor antagonists: results from the SPAIN-ALDO Registry. Endocrine. 2022;6:687–96.

Article  Google Scholar 

Chen YL, Xu TY, Xu JZ, Zhu LM, Li Y, et al. A prospective comparative study on cardiac alterations after surgery and drug treatment of primary aldosteronism. Front Endocrinol. 2021;12:770711.

Article  Google Scholar 

Zennaro MC, Boulkroun S, Fernandes-Rosa FL. Pathogenesis and treatment of primary aldosteronism. Nat Rev Endocrinol. 2020;16:578–89.

Article  CAS  PubMed  Google Scholar 

Hundemer GL, Vaidya A. Management of endocrine disease: the role of surgical adrenalectomy in primary aldosteronism. Eur J Endocrinol. 2020;183:R185–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hokotate H, Inoue H, Baba Y, Tsuchimochi S, Nakajo M. Aldosteronomas: experience with superselective adrenal arterial embolization in 33 cases. Radiology. 2003;227:401–6.

Article  PubMed  Google Scholar 

Zhang H, Li Q, Liu X, Zhao Z, He H, et al. Adrenal artery ablation for primary aldosteronism without apparent aldosteronoma: an efficacy and safety, proof-of-principle trial. J Clin Hypertens. 2020;22:1618–26.

Article  Google Scholar 

Dong H, Zou Y, He J, Deng Y, Chen Y, Song L, et al. Superselective adrenal arterial embolization for idiopathic hyperaldosteronism: 12-month results from a proof-of-principle trial. Catheter Cardiovasc Interv. 2021;97:976–81.

Article  PubMed  Google Scholar 

Qiu J, Li N, Xiong HL, Yang J, Li YD, Hu CK, et al. Superselective adrenal arterial embolization for primary aldosteronism without lateralized aldosterone secretion: an efficacy and safety, proof-of-principle study. Hypertens Res. 2023;46:1297–310.

Article  CAS  PubMed  Google Scholar 

ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 2. Classification and diagnosis of diabetes: standards of care in Diabetes-2023. Diabetes Care. 2023;46:S19–40.

Article  CAS  PubMed  Google Scholar 

Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017;5:689–99.

Article  PubMed  PubMed Central  Google Scholar 

Sun F, Liu X, Zhang H, Zhou X, Zhao Z, He H, et al. Catheter-based adrenal ablation: an alternative therapy for patients with aldosterone-producing adenoma. Hypertens Res. 2023;46:91–9.

Article  PubMed  Google Scholar 

Yang S, Wang G, Li N, Zhu Q. The outcomes of transcatheter adrenal ablation in patients with primary aldosteronism: a systematic review and meta-analysis. BMC Endocr Disord. 2023;23:103.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao Z, Liu X, Zhang H, Li Q, He H, Yan Z, et al. Catheter-based adrenal ablation remits primary aldosteronism: a randomized medication-controlled trial. Circulation. 2021;144:580–2.

Article  PubMed  Google Scholar 

Weinberger MH, Grim CE, Hollifield JW, Kem DC, Ganguly A, Kramer NJ, et al. Primary aldosteronism: diagnosis, localization, and treatment. Ann Intern Med. 1979;90:386–95.

Article  CAS  PubMed  Google Scholar 

Sukor N, Gordon RD, Ku YK, Jones M, Stowasser M. Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience. J Clin Endocrinol Metab. 2009;94:2437–45.

Article  CAS  PubMed  Google Scholar 

Lu YC, Liu KL, Wu VC, Wang SM, Lin YH, Chueh SJ, et al. Unilateral adrenalectomy in bilateral adrenal hyperplasia with primary aldosteronism. J Formos Med Assoc. 2023;122:393–9.

Article  PubMed  Google Scholar 

Szabo Yamashita T, Shariq OA, Foster TR, Lyden ML, Dy BM, Young WF, et al. Unilateral adrenalectomy for primary aldosteronism due to bilateral adrenal disease can result in resolution of hypokalemia and amelioration of hypertension. World J Surg. 2023;47:314–8.

Article  PubMed  Google Scholar 

Moran W, Goetz FC, Melby J, Zimmermann B, Kennedy BJ. Primary hyperaldosteronism without adrenal tumor. Am J Med. 1960;28:638–47.

Article  CAS  PubMed  Google Scholar 

Marín-Martínez L, Ríos-Vergara AJ, Kyriakos G, Álvarez-Martín MC, Hernández-Alonso E. Bilateral adrenalectomy in a patient with refractory primary aldosteronism due to adrenal hyperplasia. Cureus. 2022;14:e24267.

PubMed  PubMed Central  Google Scholar 

Therien B, Mellinger RC, Caldwell JR, Howard PJ.Primary aldosteronism due to adrenal hyperplasia; occurrence in a boy aged 10 years.AMA J Dis Child. 1959;98:90–9.

Article  CAS